Emcure Pharmaceuticals P/B Ratio
Emcure Pharmaceuticals (EMCURE) P/B ratio is 7.08 (High), book value per share ₹244.32 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Emcure Pharmaceuticals stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
EMCURE P/B Ratio — Valuation Insights & Book Value Analysis
Emcure Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 7.08 (High). View EMCURE price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 7.08, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.33
Emcure Pharmaceuticals P/B Ratio Historical Trend
EMCURE annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Review Emcure Pharmaceuticals price earnings to evaluate earnings-based valuation against sector peers.
EMCURE Historical P/B Ratio — Book Value Per Share & Year-End Price
Emcure Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 5.58 | ₹244.32 | ₹1364.50 | ₹4,642 | High |
| 2024 | 8.39 | ₹172.49 | ₹1447.10 | ₹3,122 | High |
EMCURE vs Healthcare Peers — P/B Ratio Comparison
Emcure Pharmaceuticals P/B 7.08 vs Healthcare average -0.33, median 0.6 — range -17.45–1.11.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.45 | ₹21 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.34 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.88 | ₹132 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |